Brooklands Fund Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,319
Closed -$7.36M 80
2025
Q4
$7.36M Buy
21,319
+4,345
+26% +$1.47M 3.46% 5
2025
Q3
$5.5M Buy
16,974
+177
+1% +$55K 6.82% 5
2025
Q2
$6.53M Hold
16,797
5.45% 4
2025
Q1
$7.3M Buy
16,797
+2,001
+14% +$803K 4.56% 5
2024
Q4
$5.45M Buy
+14,796
New +$6.19M 6.27% 6

Other funds holding ELV

Brooklands Fund Management's ELV Position: Q1 2026 in Review

Brooklands Fund Management increased its Elevance Health (ELV) stake by 1,055,250% in Q1 2026, buying an estimated $6.94M and bringing the position to 21,107 shares worth $6.2M. The position accounts for 6.97% of the portfolio, ranked #3.

Brooklands Fund Management first reported a position in ELV in Q4 2025 and has held it in 2 quarters since. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Brooklands Fund Management held 21,107 shares of Elevance Health worth $6.2M as of Q1 2026.
  • Brooklands Fund Management bought 21,105 Elevance Health shares in Q1 2026, an estimated $6.94M.
  • Elevance Health made up 6.97% of Brooklands Fund Management's portfolio in Q1 2026, its #3 holding.
  • Brooklands Fund Management first reported a position in Elevance Health in Q4 2025 and has held it in 2 quarters since.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Brooklands Fund Management's 13F filing for Q1 2026, filed 14 May 2026.